European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

African Research and Innovative Initiative for Sickle cell Education: Improving Research Capacity for Service Improvement

Descripción del proyecto

Mejores prácticas para el control de la drepanocitosis y su cribaje en recién nacidos

La drepanocitosis representa una carga social y sanitaria en todo el mundo. El proyecto financiado con fondos europeos ARISE establecerá un programa de intercambio de personal entre agencias, de carácter multidisciplinario, en las instituciones de la Unión Europea, el Reino Unido, África, Líbano y Estados Unidos para compartir mejores prácticas en el cribaje neonatal, el diagnóstico y el tratamiento de la drepanocitosis. El proyecto utilizará estrategias científicas de aplicación para fomentar la colaboración, implicar a las partes interesadas y establecer unos servicios sostenibles para las personas afectadas por la enfermedad. ARISE calculará la prevalencia de la drepanocitosis entre los ciudadanos de los países del consorcio, creará sistemas de garantía de la calidad del diagnóstico en laboratorio para el cribaje de la población, comprobará la viabilidad del cribaje neonatal y en edades tempranas, y elaborará protocolos de tratamiento para complicaciones comunes.

Objetivo

The Overarching Objective for this consortium is to establish an inter-agency and multidisciplinary staff exchange programme between researchers, technical and administrative staff interaction within EU institutions as well as reaching out to non-EU countries in Africa, Lebanon and US in order to foster sharing of best practice in Newborn Screening, diagnosis and treatment of Sickle Cell Disease (SCD) leading to improvement in overall disease outcome. Using implementation science strategies for this consortium to foster partnerships and the establishment of patient database, registries and a sustainable service for people living with the disorder.
Primary Objectives:
- To evaluate the prevalence of sickle cell disease among populations in consortium member countries and identify specific haemoglobin genotypes and phenotypic presentations;
- To establish laboratory diagnosis and quality assurance systems for population screening and setting up of SCD national prevention programmes;
- To test the feasibility for establishing newborn and early infant screening for SCD in consortium participants;
- To establish treatment protocols for common complications -acute and chronic pain, stroke, infections, severe anaemia as well as transition from paediatric to adult care, health promotion strategies and nutrition.
In order to achieve these objectives, we designed the following WPs:
Scientific Coordination and Project Management
Implementing eHealth technologies to support a Newborn screening programme in EU, African Countries and Lebanon.
Improving laboratory diagnosis and quality assurance systems for population screening.
Newborn SCD screening, screening for neurocognitive complications, clinical care and antibiotic prophylaxis
Enhancement of SCD management through training in molecular diagnostic techniques and Genetic Counseling for haemoglobinopathies and performance of epidemiological and
Training in Research and academic leadership.
Communication and dissemination

Coordinador

FONDAZIONE PER LA RICERCA FARMACOLOGICA GIANNI BENZI ONLUS
Aportación neta de la UEn
€ 147 200,00
Dirección
VIA ABATE EUSTASIO 30
70010 Valenzano Bari
Italia

Ver en el mapa

Región
Sud Puglia Bari
Tipo de actividad
Research Organisations
Enlaces
Coste total
€ 147 200,00

Participantes (12)

Socios (8)